Cargando…
A novel noninvasive formula for predicting cirrhosis in patients with chronic hepatitis C
Evaluating liver fibrosis is crucial for disease severity assessment, treatment decisions, and hepatocarcinogenic risk prediction among patients with chronic hepatitis C. In this retrospective multicenter study, we aimed to construct a novel model formula to predict cirrhosis. A total of 749 patient...
Autores principales: | Atsukawa, Masanori, Tsubota, Akihito, Kondo, Chisa, Uchida-Kobayashi, Sawako, Takaguchi, Koichi, Tsutsui, Akemi, Nozaki, Akito, Chuma, Makoto, Hidaka, Isao, Ishikawa, Tsuyoshi, Iwasa, Motoh, Tamai, Yasuyuki, Tobari, Maki, Matsuura, Kentaro, Nagura, Yoshihito, Abe, Hiroshi, Kato, Keizo, Suzuki, Kenta, Okubo, Tomomi, Arai, Taeang, Itokawa, Norio, Toyoda, Hidenori, Enomoto, Masaru, Tamori, Akihiro, Tanaka, Yasuhito, Kawada, Norifumi, Takei, Yoshiyuki, Iwakiri, Katsuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432856/ https://www.ncbi.nlm.nih.gov/pubmed/34506563 http://dx.doi.org/10.1371/journal.pone.0257166 |
Ejemplares similares
-
Factors Associated with Hepatitis B Surface Antigen Kinetics and Responses in Pegylated Interferon Alpha-2a Monotherapy for Patients with Chronic Hepatitis B
por: Itokawa, Norio, et al.
Publicado: (2021) -
Effect of Vitamin D Supplementation on Skeletal Muscle Volume and Strength in Patients with Decompensated Liver Cirrhosis Undergoing Branched Chain Amino Acids Supplementation: A Prospective, Randomized, Controlled Pilot Trial
por: Okubo, Tomomi, et al.
Publicado: (2021) -
Efficacy and safety of oral semaglutide in patients with non‐alcoholic fatty liver disease complicated by type 2 diabetes mellitus: A pilot study
por: Arai, Taeang, et al.
Publicado: (2022) -
How do the 2022 European Society of Cardiology/European Respiratory Society guidelines modify the diagnosis of portopulmonary hypertension in patients with cirrhosis complicated by portal hypertension? A post hoc analysis
por: Atsukawa, Masanori, et al.
Publicado: (2023) -
Shorter pruritus period and milder disease stage are associated with response to nalfurafine hydrochloride in patients with chronic liver disease
por: Kawano, Tadamichi, et al.
Publicado: (2022)